| Literature DB >> 23797701 |
Bo Zhang1, Jin Xu, Chen Liu, Jiang Long, Liang Liu, Yongfeng Xu, Chuntao Wu, Guopei Luo, Quanxing Ni, Min Li, Xianjun Yu.
Abstract
Pancreaticojejunostomy is the key procedure of pancreaticoduodenectomy. Our study introduced a new pancreaticojejunal (PJ) anastomosis named "papillary-like main pancreatic duct invaginated" pancreaticojejunostomy. Nighty-two patients underwent pancreaticojejunostomy with either conventional duct-to-mucosa pancreaticojejunostomy or the new "papillary-like main pancreatic duct invaginated" techniques were analyzed retrospectively from January 2010 to September 2012. The incidence of pancreatic fistula was 15.7% (8/51) for the "papillary-like main pancreatic duct invaginated" group and 19.5% (8/41) for the duct-to-mucosa fashion respectively. It is noteworthy that the rate of grade B/C postoperative pancreatic fistula (POPF) in the "papillary-like main pancreatic duct invaginated" group was significantly lower than that of the duct-to-mucosa group (P = 0.039). There were no differences in the incidence of postoperative morbidity and mortality such as postoperative hemorrhage, delayed gastric emptying or remnant pancreatitis. The "papillary-like main pancreatic duct invaginated" pancreaticojejunostomy could provide a feasible option to pancreatic surgeons for patients with normal soft pancreas.Entities:
Mesh:
Year: 2013 PMID: 23797701 PMCID: PMC3691567 DOI: 10.1038/srep02068
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Preoperative data in two groups
| Duct-to-Mucosa (n = 41) | Papillary-like (n = 51) | P value | |
|---|---|---|---|
| Median Age | 56.9 ± 10.8 | 57.7 ± 12.6 | 0.745 |
| Sex (male) | 23 | 26 | 0.625 |
| Median body mass index(BMI) | 22.0 ± 1.0 | 21.7 ± 1.1 | 0.104 |
| Pathological types | 0.464 | ||
| Duodenal tumor | 7 | 14 | |
| Ampullary cancer | 19 | 19 | |
| Pancreatic neoplasms | 15 | 18 |
a: including Duodenal cancer, Gastrointestinal stromal tumor (GIST).
b: including Bile duct cancer, Duodenal papilla cancer, Cancer of Vater ampulla.
c: including Solid pseudopapillary carcinoma, Neuroendocrine tumor, Benign cystadenoma,Pancreatic cyst, Intraductal papillary mucinous neoplasm (IPMN), Pancreatic uncinate process cancer.
Operative related data in two groups
| Duct-to-Mucosa(n = 41) | Papillary-like(n = 51) | P value | |
|---|---|---|---|
| Operative time (min) | 398.9 ± 61.9 | 401.3 ± 59.2 | 0.848 |
| Intraoperative blood loss (ml) | 406.5 ± 125.4 | 407.0 ± 159.1 | 0.988 |
| Diameter of pancreatic duct (mm) | 2.8 ± 0.2 | 2.7 ± 0.2 | 0.114 |
| Anastomotic time (min) | 20.6 ± 3.5 | 20.7 ± 2.1 | 0.902 |
| Operative procedure | 0.884 | ||
| PPPD | 11 | 13 | |
| PD | 30 | 38 | |
| Hospital stay time (d) | 23.6 ± 10.8 | 20.2 ± 10.0 | 0.121 |
PPPD: Pylorus-preserved pancreaticoduodenectomy.
PD: pancreaticoduodenectomy.
Postoperative morbidity and mortality of two groups
| Duct-to-Mucosa(n = 41) | Papillary-like(n = 51) | P value | |
|---|---|---|---|
| Delayed gastric emptying | 2 | 2 | 0.823 |
| Intra-abdominal abscess | 1 | 0 | 0.262 |
| Remnant pancreatitis | 1 | 1 | 0.876 |
| Reoperation patient | 1 | 0 | 0.262 |
| POPF | 0.039 | ||
| Grade A | 3 | 7 | |
| Grade B/C | 5 | 1 |
Blood Amylase, BG and WBC between the two groups on POD1, 3
| Duct-to-Mucosa (n = 41) | Papillary-like (n = 51) | P value | |
|---|---|---|---|
| Postoperative blood amylase (U/L) | |||
| D1 | 75.4 ± 70.3 | 69.8 ± 68.1 | 0.702 |
| D3 | 49.9 ± 36.8 | 43.1 ± 34.1 | 0.361 |
| Postoperative BG (mmol/L) | |||
| D1 | 10.1 ± 2.4 | 10.2 ± 2.0 | 0.836 |
| D3 | 9.7 ± 1.5 | 10.2 ± 1.7 | 0.182 |
| Postoperative WBC counts (×109/L) | |||
| D1 | 13.2 ± 2.7 | 13.7 ± 2.1 | 0.300 |
| D3 | 11.7 ± 1.8 | 12.0 ± 2.4 | 0.497 |
Figure 1Management of the pancreatic stump.
(A) A 1–1.2 cm pancreatic stump was isolated. (B) The pancreatic stump was molded into a “fish mouth-like” shape, with the pancreatic duct protruding out of the stump. The pancreatic stump was closed with interrupted inverting sutures around the “papillary-like main pancreatic duct”.
Figure 2Treatment of the posterior wall of “papillary-like main pancreatic duct invaginated” pancreaticojejunostomy.
(A) The back wall of pancreatic stump and the seromuscular layer of jejunum were sewn together using 4-0 absorbable sutures by interrupted sutures. (B) A small full-thickness enterotomy was penetrated on the jejunal wall for connecting to the “papillary-like main pancreatic duct”.
Figure 3Treatment of the anterior wall of “papillary-like main pancreatic duct invaginated” pancreaticojejunostomy.
(A) The “papillary-like main pancreatic duct” is invaginated into the jejunum hole firmly by placing 4–6 sutures from the “periductal” parenchyma to the whole-layer jejunum hole. (B) The interrupted sutures between the front wall of pancreatic stump and the seromuscular jejunum were performed by 4-0 absorbable sutures to complete the anastomosis.
Figure 4Diagrammatic illustration of the anastomosis and drain management.
After the completion of the anastomosis, one drain was placed anterior to the PJ anastomosis and another posterior to the anastomosis.